Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Apr 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zeo ScientifiX's total debt was $247.00K at Apr 30, 2026. For fiscal 2025 it was $243.00K, down 64.3% from the year before. The highest annual figure on record is $680.00K in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $243.00K | -64.3% |
| FY2024 | Oct 31, 2024 | $680.00K | +3.5% |
| FY2023 | Oct 31, 2023 | $657.00K | +2198.2% |
| FY2022 | Oct 31, 2022 | $28.59K | -79.6% |
| FY2021 | Oct 31, 2021 | $140.43K | +108.6% |
| FY2020 | Oct 31, 2020 | $67.32K | -56.1% |
| FY2019 | Oct 31, 2019 | $153.18K | – |
| FY2018 | Oct 31, 2018 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $247.00K | -64.3% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $245.00K | -64.3% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $243.00K | -64.3% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $698.00K | +4.3% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $692.00K | +4.4% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $686.00K | +4.4% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $680.00K | +45.3% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $669.00K | +113.1% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $663.00K | +2219.2% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $657.00K | +505.7% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $468.05K | +233.3% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $314.00K | +366.4% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $28.59K | -81.3% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $108.46K | -34.6% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $140.43K | -20.8% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $67.32K | – |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $153.18K | – |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $165.78K | – |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $177.40K | – |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $0 | – |
See a number that looks wrong?